A Monash-led research team has discovered a new link between disturbed blood flow and blood clotting, which is identified as the precise mechanism by which these changes activate the clotting process. This discovery may explain the lack of effectiveness of commonly used anti-clotting therapies.
A new catheter-based treatment has been successfully trialled to reduce high blood pressure in patients who resist conventional drug treatments. The technique, which disrupts nerves around the kidneys, showed a large and persistent decrease in blood pressure.
Babies born to mothers who smoke are more likely to have impaired arousal responses and increased risk of Sudden Infant Death Syndrome (SIDS). The study suggests that maternal smoking can impair a baby's ability to respond to external stimuli, which may explain their increased risk of SIDS.
Researchers used computer modeling to reconstruct a 1100km subducted tectonic plate and found a connection between New Caledonia and northern New Zealand. The discovery provides evidence of a geographical link between the two islands at that time, shedding light on evolution in the region.
Researchers uncover way to genetically modify Clostridium difficile and solve mystery surrounding its toxicity, revealing toxin B as the cause of severe disease. The discovery has the potential to save lives and healthcare systems billions of dollars annually.
Researchers at Monash University have made a breakthrough in treating malaria by deactivating the parasite's digestive machinery. The discovery could provide treatment for millions of people worldwide and offers hope against drug-resistant malaria.
Honeybees can learn to recognise human faces even when seen from different viewpoints due to their ability to interpolate or image average previously learnt views. The study suggests that bee brains have evolved clever mechanisms for problem solving which may help develop improved models for AI face recognition systems.
Researchers at Monash University found a new drug, tasimelteon, that can effectively shift melatonin levels to alleviate jet lag and sleep disorders. The drug has the potential to improve sleep quality for patients with transient insomnia caused by time zone changes.
A Monash University scientist has discovered that appetite-suppressing cells in the human brain degenerate over time, leading to increased hunger and potential weight gain. The research found that free radicals attack these cells after eating meals rich in carbohydrates and sugars.
The team's breakthrough design features a Goretex-coated air-electrode that is more economical, easily sourced, and outlasts traditional platinum cells. Testing has shown no degradation or performance loss over 1500 hours of continuous use.
Monash University scientists have initiated a clinical trials program for a footrot vaccine using reverse vaccinology to identify potential antigens. The goal is to develop a cross-protective vaccine that could significantly reduce the financial impact of footrot on the Australian wool and livestock industry.
Researchers at Monash University uncover a molecular arms race between bacteria and the human immune system, revealing perforins as key players in defense against bacterial toxins. The discovery could lead to new ways to fight disease, including infectious diseases and transplantation rejection.
Astrophysicists have resolved a long-standing issue with the Big Bang theory by studying gas movements in stars. Computer models revealed that low mass stars destroy helium 3 before it can be released into space, resolving the discrepancy.
A 380 million-year-old fossil fish discovery in Western Australia rewrites land mammal evolution, tracing human adaptations to life on land further back in time than previously thought. The Gogonasus fossil reveals features of tetrapods evolved earlier than expected.
Australian scientists identified a toxin produced by E. coli bacteria that causes severe gastrointestinal illnesses, including food poisoning and haemolytic uraemic syndrome. The research breakthrough may provide insights into age-related diseases like Parkinson's and Alzheimer's, as well as cancer treatments.
A team of Monash University scientists has identified two proteins, Smad3 and c-Myc, involved in stopping telomerase production. This discovery could lead to the development of anti-cancer agents that mimic these proteins.